摘要:
The invention relates to alkylsulfide derivatives compounds of formula I as hereunder depicted or the enantiomers or veterinarily acceptable salts thereof which are useful for combating or controlling invertebrate pests, in particular arthropod pests and nematodes. The invention also relates to methods for controlling invertebrate pests by using these compounds and to plant propagation material and to agricultural and veterinary compositions comprising said compounds. wherein U, R1, R2, R3U, X, n and p are defined as in the description.
摘要:
The invention provides crystalline salt forms of 4′-{2-ethoxy-4-ethyl-5-[((S)-2-mercapto-4-methylpentanoylamino)methyl]-imidazol-1-ylmethyl}-3′-fluorobiphenyl-2-carboxylic acid. This invention also provides pharmaceutical compositions comprising the crystalline compounds, processes and intermediates for preparing the crystalline compounds, and methods of using the crystalline compounds to treat diseases such as hypertension.
摘要:
Methods and intermediates useful for making compounds of the formula: and the preparation of compounds of Formula I, preferably including the formation of intermediate compounds of the formula:
摘要:
This invention provides compounds having the structural formula: wherein: R1 is an acyl or sulfonyl group, R2 is an acyl group selected from the group consisting of acyl groups derived from cycloaliphatic, aromatic or heterocyclic monocarboxylic acids, imidazolylcarbonyl and triazolylcarbonyl, and R3 is hydrogen or an amino-protecting group, a stereoisomer thereof, a solvate thereof, or a salt thereof, being useful as anti-inflammatory agents and anti-cancer agents.
摘要:
New 1,2,3- or 1,2,3,4- or 1,2,3,4,5- substituted imidazolium salts and their uses as solvent in catalyzed organic reactions, as well as compositions containing them and a transition metal compound. They can be used in the following reactions: the telomerisation of conjugated dienes, dimerisation of olefins, the oligomerisation of olefins, polymerization of olefins, alkylation of olefins, hydrogenation of olefins, olefin metathesis, hydroformylation of olefins, ring-closing metathesis of olefins, ring-opening metathesis polymerisation of olefins, symetric or asymetric epoxidation of olefins (including heteroatom substituted olefins) and the cyclopropanation of olefins, condensation reaction, hydrogenation reaction, isomerization reaction, Suzuki cross-coupling reactions, amination reaction, partial oxidation of alkancs, kinetic resolution of racemic mixtures, hydrogenation of imines, hydrogenation of ketones, transfer hydrogenation and hydroxylation of aromatic organic compounds.
摘要:
Novel compounds, compositions, and kits are provided. Methods of modulating Aβ levels, and methods of treating a disease associated with aberrant Aβ levels are also provided.
摘要:
The present invention relates to novel compounds having a positive allosteric GÀBAB receptor (GDR) modulator effect, methods for the preparation of said compounds and to their use, optionally in combination with a GABAB agonist, for the inhibition of transient lower esophageal sphincter relaxations, for the treatment of gastroesophageal reflux disease, as well as for the treatment of functional gastrointestinal disorders and irritable bowel syndrome (IBS). A compound of the general formula I.
摘要:
Compounds of the formula (I), in which R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11, X and X′ have the meanings indicated in claim 1, are inhibitors of tyrosine kinases, in particular TIE-2, and Raf kinases and can be employed, inter alia, for the treatment of tumours.
摘要翻译:式(I)的化合物,其中R 1,R 2,R 3,R 4, R 5,R 6,R 7,R 8,R 9, R 10,R 11,X和X'具有权利要求1所示的含义,是酪氨酸激酶,特别是TIE-2和Raf激酶的抑制剂,可以是 尤其用于治疗肿瘤。
摘要:
Disclosed are compounds which bind VLA-4. Certain of these compounds also inhibit leukocyte adhesion and, in particular, leukocyte adhesion mediated by VLA-4. Such compounds are useful in the treatment of inflammatory diseases in a mammalian patient, e.g., human, such as asthma, Alzheimer's disease, atherosclerosis, AIDS dementia, diabetes, inflammatory bowel disease, rheumatoid arthritis, tissue transplantation, tumor metastasis and myocardial ischemia. The compounds can also be administered for the treatment of inflammatory brain diseases such as multiple sclerosis.
摘要:
Compounds of formula (I) or a pharmaceutically acceptable salt thereof, having 5HT2C receptor activity, are disclosed: wherein a is 0,1,2,3,4 or 5; b is 1,2 or 3; Y is nitrogen or carbon; A is oxygen, nitrogen, —CONH—, —NHCO— or together with R2 form a benzoxazolone group; R1 is halogen, C1-6alkyl, C1-6alkoxy, C1-6alkylthio, hydroxy, amino, mono- or di-C1-6alkylamino, nitro, CN, CF3, OCF3, aryl, arylC1-6alkyl, arylC1-6alkyloxy or arylC1-6alkylthio; R2 is hydrogen, halogen, C1-6alkyl, C1-6alkoxy, haloC1-6alkyl or haloC1-6alkoxy; R3 is: (i) —NR4R5 where R4 and R5 are independently hydrogen, C1-6alkyl or arylC1-6alkyl; or (ii) an optionally substituted N-linked heterocycle; or (iii) an optionally substituted C-linked heterocycle; ======= is a single bond or a double bond; and X is CH2 or C═O (when ======= is a single bond) or X is CH (when ======= is a double bond). The preparation of these compounds and their use in therapy, especially for a CNS disorder such as depression or anxiety, are also disclosed.
摘要翻译:公开了具有5HT 2C受体活性的式(I)化合物或其药学上可接受的盐:其中a为0,1,2,3,4或5; b为1,2或3; Y是氮或碳; A是氧,氮,-CONH-,-NHCO-或与R 2一起形成苯并恶唑酮基团; R 1是卤素,C 1-6烷基,C 1-6烷氧基,C 1-6烷基硫基 ,羟基,氨基,单或二-C 1-6烷基氨基,硝基,CN,CF 3,OCF 3,芳基,芳基C C 1-6烷基,芳基C 1-6烷氧基或芳基C 1-6烷硫基; R 2是氢,卤素,C 1-6烷基,C 1-6烷氧基,卤素C 1-6 烷基或卤代C 1-6烷氧基; R 3是:(i)-NR 4 R 5,其中R 4和R 5, / SUP>独立地为氢,C 1-6烷基或芳基C 1-6烷基; 或(ii)任选取代的N-连接的杂环; 或(iii)任选取代的C连接的杂环; =======是单一债券或双重债券; X为CH 2或C-O(当=======为单键时)或X为CH(当=======为双键时)。 还公开了这些化合物的制备及其在治疗中的用途,特别是用于抑制或焦虑等CNS病症。